DMEMEDS shared post via Reuters: Novartis submits meningitis B drug for U.S. approval

ZURICH (Reuters) - Swiss drugmaker Novartis said on Tuesday it had submitted its meningitis B vaccine Bexsero for adolescents and young people to the U.S. Food and Drug Administration (FDA) for marketing approval. [Category: healthNews] http://feeds.reuters.com/~r/reuters/healthNews/~3/1BiMAsC0HgE/story01.htm

Read More